I think what intrigues me most about EDAP and HIFU is the potential treatment of other forms of cancer besides prostate cancer. With ten years of European data and now the U.S. clinical trials underway, this company provides a quality investment at a relatively good price. So far, all the news has been fairly positive. I think we'll see $20 + again soon. Of course, with FDA approval, the sky's the limit. Does anyone know when we can expect to hear some results from the U.S. clinical trials?
Not sure about in the States but with all the publicity, conventions, patients and families and medical professionals connected with EDAP now it's nice to see a European weigh in here. There's only a seven million share or so float. Good luck my friend.
There is a 2 year follow up after the last patient is treated. Also, the FDA may have questions that will delay the approval, this almost always happens, especially with new technology. EDAP has stated that they do not think they will get approval before 2009 and have even said that it may be 2010. Even if it is 2009 reimbursements will lag for awhile until insurance contracts are signed so I don't see a big contribution to earnings until 2010 at the earliest.
The FDA moves slowly and I personally do not expect approval until a year or so.
Go to www.clinical trials.gov and look up ablatherm. Tests aRE underway at Duke, Baylor etc.--and when the USA catches up with the rest of the world this WILL be approved. It is currently being used in Europe, China, Canada etc. Pull up HIFU under www.Google.com.
Look at the hole page for EDAP.
As a prostate cancer survivor I had surgery. However, some can not have surgery because of health reasons and HIFU is an alternative.
Prostate problems are not "fun" but a fact of life which an aging population will have to face.
Best wishes! IAM A FIRM BELIEVER IN EDAP FOR THE LONG TERM> Day traders will not like this stock.